Review: taking Ritalin and Risperdal consta together


Summary

Drug interactions are reported among people who take Ritalin and Risperdal consta together. This review analyzes the effectiveness and drug interactions between Ritalin and Risperdal consta. It is created by eHealthMe based on reports of 1,148 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Ritalin and Risperdal consta >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Ritalin

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Ritalin 11,167 users)

Risperdal Consta

Risperdal consta has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperdal consta 5,051 users)

On Jul, 25, 2016

1,148 people who take Ritalin, Risperdal Consta are studied.


Number of reports submitted per year:

Ritalin and Risperdal consta drug interactions.

Drug effectiveness over time:

Ritalin:
  • < 1 month: 36.0% - (4 of 11 people)
  • 1 - 6 months: 0.0% - (0 of 9 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 57.0% - (12 of 21 people)
  • 2 - 5 years: 33.0% - (5 of 15 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 1 people)
Risperdal Consta:
  • < 1 month: 18.0% - (2 of 11 people)
  • 1 - 6 months: 25.0% - (3 of 12 people)
  • 6 - 12 months: 14.0% - (1 of 7 people)
  • 1 - 2 years: 23.0% - (3 of 13 people)
  • 2 - 5 years: 38.0% - (5 of 13 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 50.0% - (1 of 2 people)

Drug effectiveness by gender:

Ritalin:
  • female: 37.0% - (9 of 24 people)
  • male: 41.0% - (16 of 39 people)
Risperdal Consta:
  • female: 22.0% - (5 of 22 people)
  • male: 29.0% - (12 of 41 people)

Drug effectiveness by age:

Ritalin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 20.0% - (3 of 15 people)
  • 10-19: 40.0% - (9 of 22 people)
  • 20-29: 33.0% - (4 of 12 people)
  • 30-39: 50.0% - (4 of 8 people)
  • 40-49: 100.0% - (4 of 4 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)
Risperdal Consta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 12.0% - (2 of 16 people)
  • 10-19: 25.0% - (5 of 20 people)
  • 20-29: 38.0% - (5 of 13 people)
  • 30-39: 50.0% - (4 of 8 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • agitation
  • aggression
  • dyskinesia
  • convulsion
  • rhabdomyolysis
  • tachycardia
  • cytolytic hepatitis
  • dehydration
  • hyperthermia
  • renal failure acute
1 - 6 months:
  • abnormal behaviour
  • type 1 diabetes mellitus
  • weight increased
  • diabetes mellitus
  • hallucination, visual
  • insomnia
  • chest discomfort
  • essential hypertension
  • impulse-control disorder
  • nasal congestion
6 - 12 months:
  • tachycardia
  • fatigue
  • tic
  • aggression
  • cough
  • hyperhidrosis
  • night sweats
  • abnormal behaviour
  • blood triglycerides increased
  • type 2 diabetes mellitus
1 - 2 years:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • obesity
  • decreased appetite
  • tardive dyskinesia
  • tic
  • weight decreased
  • blood pressure increased
  • sensation of foreign body
  • tachycardia
2 - 5 years:
  • agitation
  • dyskinesia
  • aggression
  • dehydration
  • renal failure acute
  • cytolytic hepatitis
  • hyperthermia
  • rhabdomyolysis
  • tachycardia
  • altered state of consciousness
5 - 10 years:
  • type 2 diabetes mellitus
  • abnormal behaviour
  • blood triglycerides increased
  • type 1 diabetes mellitus
  • depression
  • depression suicidal
  • weight increased
  • blood glucose fluctuation
  • drug effect decreased
  • dry mouth
10+ years:
  • abnormal behaviour
  • affective disorder
  • coordination abnormal
  • disturbance in attention
  • dry mouth
  • dyskinesia
  • dystonia
  • muscular weakness
  • musculoskeletal stiffness
  • tardive dyskinesia
not specified:
  • aggression
  • weight increased
  • insomnia
  • abnormal behaviour
  • drug ineffective
  • depression
  • agitation
  • diabetes mellitus
  • suicidal ideation
  • anxiety

Most common drug interactions by gender *:

female:
  • diabetes mellitus
  • depression
  • weight increased
  • dizziness
  • insomnia
  • type 2 diabetes mellitus
  • pain
  • suicidal ideation
  • anxiety
  • weight decreased
male:
  • aggression
  • abnormal behaviour
  • weight increased
  • agitation
  • tachycardia
  • insomnia
  • dyskinesia
  • drug ineffective
  • convulsion
  • diabetes mellitus

Most common drug interactions by age *:

0-1:
  • aggression
  • convulsion
  • agitation
  • foaming at mouth
  • pancreatitis acute
  • tardive dyskinesia
2-9:
  • aggression
  • dyskinesia
  • tachycardia
  • agitation
  • abnormal behaviour
  • hyperthermia
  • dehydration
  • dystonia
  • cytolytic hepatitis
  • renal failure acute
10-19:
  • weight increased
  • abnormal behaviour
  • aggression
  • insomnia
  • diabetes mellitus
  • drug ineffective
  • weight decreased
  • attention deficit/hyperactivity disorder
  • suicide attempt
  • agitation
20-29:
  • dizziness
  • dyspnoea
  • insomnia
  • asthenia
  • completed suicide
  • deep vein thrombosis
  • hallucination, auditory
  • headache
  • respiratory failure
  • weight decreased
30-39:
  • diabetes mellitus
  • depression
  • insomnia
  • suicidal ideation
  • priapism
  • ventricular tachycardia
  • palpitations
  • aggression
  • anxiety
  • liver function test abnormal
40-49:
  • type 2 diabetes mellitus
  • depression
  • blood cholesterol increased
  • insomnia
  • obesity
  • road traffic accident
  • speech disorder
  • chest pain
  • nausea
  • somnolence
50-59:
  • type 2 diabetes mellitus
  • dizziness
  • weight increased
  • extrapyramidal disorder
  • muscle twitching
  • paraesthesia
  • parkinsonism
  • sedation
  • diabetes mellitus
  • diabetic neuropathy
60+:
  • dyspnoea
  • pain
  • anxiety
  • depression
  • atrial fibrillation
  • back pain
  • cardiac failure congestive
  • drug ineffective
  • hypotension
  • oedema peripheral

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Ritalin and Risperdal consta?

Can you answer these questions?

More questions for: Ritalin, Risperdal consta

You may be interested in these reviews

More reviews for: Ritalin, Risperdal consta

On eHealthMe, Ritalin (methylphenidate hydrochloride) is often used to treat attention deficit hyperactivity disorder. Risperdal consta (risperidone) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.